Militello John

See RemarksROCKET PHARMACEUTICALS, INC. (RCKT) · full profile →Form 4 · filed May 28, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
17
0 non-derivative · 17 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 26, 2026Disposed to issuer(D)10K0
May 26, 2026Disposed to issuer(D)10K0
May 26, 2026Disposed to issuer(D)20K0
May 26, 2026Disposed to issuer(D)10K0
May 26, 2026Disposed to issuer(D)20K0
May 26, 2026Disposed to issuer(D)2K0
May 26, 2026Disposed to issuer(D)18K0
May 26, 2026Disposed to issuer(D)18K0
May 26, 2026Disposed to issuer(D)27K0
May 26, 2026Disposed to issuer(D)29K0
May 26, 2026Disposed to issuer(D)50K0
May 26, 2026Disposed to issuer(D)25K0
May 26, 2026Grant(A)52K52K
May 26, 2026Grant(A)15K15K
May 26, 2026Grant(A)16K16K
May 26, 2026Grant(A)25K25K
May 26, 2026Grant(A)9K9K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-26-023153) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.